Biotechnology
| Fri 18 Jul 2025
Alexandria, July 18 -- U.S. Patent and Trademark Office has awarded a patent to Novavax for modified RSV F proteins and methods of their use. Pushko Peter M, Wu Yingyun, Massare Michael J, Liu Ye, Smith Gale and Zhou Bin developed the invention.
The patent application number is US202217818887 20220810. The patent publication ..